Abstract
Lividomycin (LVM) was effective to acute suppurative diseases, being the effectiveness 58.4%. None of the patients had any side effect.It seems unnecessary to worry about the side effects so far as LVM is administered for less than one week and patients have no underlying diseases.
The MIC of LVM against Staphylococcus aureus isolated from lesions is about 31.3mcg/ml.LVM is almost equal to KM but inferior to GM in antimicrobial activity.LVM seems to have a cross resistance with KM and GM in S.aureus.LVM is superior to KM, but inferior to GM in its antimicrobial activity against Pseudomonas aeruginosa isolated from lesions.
LVM is not especially superior to other existing antibiotics for the treatment of pyoderma. Therefore, LVM will not be used as a drug of first choice for patients with dermatological diseases.
